Evaluation of formaldehyde as an ocular irritant: a systematic review and Meta-analysis.

Formaldehyde eye formaldehyde/poisoning laboratories meta-analysis

Journal

Cutaneous and ocular toxicology
ISSN: 1556-9535
Titre abrégé: Cutan Ocul Toxicol
Pays: England
ID NLM: 101266892

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 27 12 2018
medline: 9 8 2019
entrez: 27 12 2018
Statut: ppublish

Résumé

The aim of this study was to use meta-regression to evaluate the safety of the maximum allowable dose of formaldehyde in terms of eye irritation symptoms. We performed a systematic review of literature published in the PubMed, Embase, Lilacs, Web of Science, and Cochrane Library databases. We selected clinical trials, cohort studies, and case-control studies that compared eye irritation between patients exposed and not exposed to formaldehyde. Eighteen of the 2561 studies retrieved met the inclusion criteria. Data were extracted using structured forms and study quality was analyzed using the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) checklist. Odds ratios (ORs) were calculated using a random effects model with stratification by airborne dose and subsequent meta-regression analysis. The random effects model yielded an OR of 8.11 (95% CI: 5.85-10.37), with an I2 statistic of 99.8% and p < 0.00001. In the meta-regression analysis, we observed an I2 of 87.29% with an R2 of 23.96; the regression line for exposure had a slope of 1.466 (95% CI: 0.096-2.836) in relation to the Napierian log of the OR. Considering a safety level based on an OR of 2 relative to the unexposed group, an airborne concentration of formaldehyde of less than 0.001 mg/m3 can be considered safe. Although current formaldehyde exposure concentrations are relatively safe in terms of cancer risk, they continue to cause eye irritation.

Identifiants

pubmed: 30585508
doi: 10.1080/15569527.2018.1561709
doi:

Substances chimiques

Irritants 0
Formaldehyde 1HG84L3525

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Pagination

169-175

Auteurs

Pedro Vazquez-Ferreiro (P)

a Ophthalmologic Department , Hospital Virxen da Xunqueira , Cee , Spain.

Francisco Javier Carrera Hueso (FJ)

b Pharmacy Service , Hospital Dr Moliner , Serra , Spain.

Belén Alvarez Lopez (B)

a Ophthalmologic Department , Hospital Virxen da Xunqueira , Cee , Spain.

Marta Diaz-Rey (M)

a Ophthalmologic Department , Hospital Virxen da Xunqueira , Cee , Spain.

Xavier Martinez-Casal (X)

c Pharmacy Department , Hospital Virxe da Xunqueira , Cee , Spain.

Maria Auxiliadora Ramón Barrios (MA)

d Grade of Nurse , Hospital Dr Peset , Valencia , Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH